Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

TCRXTCRX
Showing 7 of 14 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in TSCAN THERAPEUTICS INC

JANE STREET GROUP, LLC holds 241,493 shares of TCRX (TSCAN THERAPEUTICS INC), worth $236,687 as of 2026-Q2. The position was increased (+67.2% shares).

Current Value

$236,687

Current Shares

241,493

Total Value Change

-$230,815

Total Shares Change

+147,617

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
241,493
+67.2%
$236,6870.0%$0.98
23
2026-Q1
Decreased
144,421
-62.8%
$145,8650.0%$1.03
0
2025-Q4
Increased
388,284
+377.5%
$388,2840.0%$1.03
38
2025-Q3
Decreased
81,316
-61.9%
$147,9950.0%$1.74
0
2025-Q2
New
213,396
-
$309,4240.0%$1.40
32
2024-Q4
Exited
0
-100.0%
$00.0%$3.00
0
2024-Q3
Decreased
93,876
-5.2%
$467,5020.0%$5.04
0

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used